KAO JOHN E 4
4 · Alignment Healthcare, Inc. · Filed Jan 14, 2026
Insider Transaction Report
Form 4
KAO JOHN E
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2][F3][F4]2026-01-12$21.10/sh−177,273$3,740,407→ 2,835,368 total(indirect: See Footnote) - Sale
Common Stock
[F1][F5][F3][F4]2026-01-12$21.57/sh−2,727$58,812→ 2,832,641 total(indirect: See Footnote)
Holdings
- 1,568,379
Common Stock
[F3]
Footnotes (5)
- [F1]Date of Rule 10b5-1 plan adoption: 03/12/2025
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.48 to $21.47. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Balances in column 5 reflect the transfer on 01/08/2026 of 665,915 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- [F4]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- [F5]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.48 to $21.67. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao|2026-01-14